CY2465B1 - Use of allylamine derivatives such as terbinafine,in the manufacture of a medicament for the treatm ent of helicobacter pylori infection of associateddiseases. - Google Patents

Use of allylamine derivatives such as terbinafine,in the manufacture of a medicament for the treatm ent of helicobacter pylori infection of associateddiseases.

Info

Publication number: CY2465B1
Authority: CY; Cyprus
Prior art keywords: associateddiseases; terbinafine; medicament; pylori infection; manufacture
Prior art date: 1995-07-06

Application number

CY0400055A

Other languages

English (en)

Inventor

Ivan James Dalton Lindley

Neil Stewart Ryder

Original Assignee

Ciba Geigy Ag

Novartis Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-07-06

Filing date

2004-07-02

Publication date

2005-06-03

2004-07-02 Application filed by Ciba Geigy Ag, Novartis Gmbh filed Critical Ciba Geigy Ag

2005-06-03 Publication of CY2465B1 publication Critical patent/CY2465B1/xx

Links

VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical class NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 title 1
206010019375 Helicobacter infections Diseases 0.000 title 1
239000003814 drug Substances 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
-1 terbinafine Chemical class 0.000 title 1
DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 title 1
229960002722 terbinafine Drugs 0.000 title 1
238000011282 treatment Methods 0.000 title 1
239000003795 chemical substances by application Substances 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
239000012458 free base Substances 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
150000003839 salts Chemical group 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Emergency Medicine (AREA)
Nutrition Science (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Hydrogenated Pyridines (AREA)
Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)

CY0400055A 1995-07-06 2004-07-02 Use of allylamine derivatives such as terbinafine,in the manufacture of a medicament for the treatm ent of helicobacter pylori infection of associateddiseases. CY2465B1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9513750.1A GB9513750D0 (en)	1995-07-06	1995-07-06	Use of allylamines

Publications (1)

Publication Number	Publication Date
CY2465B1 true CY2465B1 (en)	2005-06-03

Family

ID=10777201

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CY0400055A CY2465B1 (en)	1995-07-06	2004-07-02	Use of allylamine derivatives such as terbinafine,in the manufacture of a medicament for the treatm ent of helicobacter pylori infection of associateddiseases.

Country Status (26)

Country	Link
US (1)	US5935998A (de)
EP (1)	EP0863752B1 (de)
JP (1)	JP3680950B2 (de)
KR (1)	KR100425401B1 (de)
CN (1)	CN1204881C (de)
AT (1)	ATE232723T1 (de)
AU (1)	AU715270B2 (de)
CA (1)	CA2219678C (de)
CY (1)	CY2465B1 (de)
CZ (1)	CZ289440B6 (de)
DE (1)	DE69626301T2 (de)
DK (1)	DK0863752T3 (de)
ES (1)	ES2192608T3 (de)
GB (1)	GB9513750D0 (de)
HU (1)	HU224311B1 (de)
IL (1)	IL122853A (de)
MX (1)	MX9710093A (de)
MY (1)	MY132436A (de)
NO (1)	NO317496B1 (de)
PL (1)	PL187704B1 (de)
RU (1)	RU2193402C2 (de)
SI (1)	SI0863752T1 (de)
SK (1)	SK282874B6 (de)
TW (1)	TW522011B (de)
WO (1)	WO1997002026A1 (de)
ZA (1)	ZA965749B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0001315D0 (en) *	2000-01-20	2000-03-08	Novartis Ag	Organic compounds
US7244703B2 (en)	2001-06-22	2007-07-17	Bentley Pharmaceuticals, Inc.	Pharmaceutical compositions and methods for peptide treatment
KR20030066186A (ko) *	2002-02-05	2003-08-09	한솔케미언스 주식회사	(ｅ)-터비나핀 또는 이의 염산염의 제조방법
RU2236228C2 (ru) *	2002-11-14	2004-09-20	Российский государственный медицинский университет	Способ профилактики рецидивов кровотечений из язв и эрозий при язвенной болезни желудка и двенадцатиперстной кишки, ассоциированной с helicobacter pylori
KR100978717B1 (ko)	2003-12-08	2010-08-30	씨펙스 파마슈티칼스, 인코포레이티드	인슐린 치료를 위한 약제 조성물 및 방법
RU2269353C1 (ru) *	2004-06-10	2006-02-10	ФГУП Государственный научно-исследовательский институт особо чистых биопрепаратов	Способ лечения malt-лимфом желудка
RU2449805C1 (ru)	2011-01-27	2012-05-10	Общество С Ограниченной Ответственностью "Гармония"	Пептидная фармацевтическая композиция, средство на ее основе для лечения гастродуоденальных заболеваний, вызываемых helicobacter pylori, и способ его использования

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2716943C2 (de) *	1976-04-28	1986-08-14	Sandoz-Patent-GmbH, 7850 Lörrach	N-(3-Phenyl-2-propenyl)-N-(1-naphthylmethyl)-amine, ihre Verwendung und Herstellung
EP0000896B1 (de) *	1977-08-19	1982-10-13	Sandoz Ag	Propenyl-amine, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten
DE3020113A1 (de) *	1979-06-08	1980-12-18	Sandoz Ag	2-(1-naphthyl)piperidin-derivat, dessen herstellung sowie die verwendung als antimykotika
US5132459A (en) *	1979-08-22	1992-07-21	Sandoz Ltd.	Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
CY1410A (en) *	1979-08-22	1988-04-22	Sandoz Ag	Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
US4894375A (en) *	1986-09-29	1990-01-16	Merck & Co., Inc.	Method of controlling mycotic infections and compositions therefor
CA2020888A1 (en) *	1989-07-27	1991-01-28	Philippe Guerry	Substituted aminoalkoxybenzene derivatives
US5200195A (en) *	1991-12-06	1993-04-06	Alza Corporation	Process for improving dosage form delivery kinetics
DE4317449A1 (de) *	1993-05-19	1994-11-24	Asche Ag	Arzneimittel zur Behandlung von Erkrankungen des Magen-Darm-Traktes

1995
- 1995-07-06 GB GBGB9513750.1A patent/GB9513750D0/en active Pending
1996
- 1996-07-05 CN CNB96195289XA patent/CN1204881C/zh not_active Expired - Fee Related
- 1996-07-05 MX MX9710093A patent/MX9710093A/es not_active IP Right Cessation
- 1996-07-05 HU HU9802929A patent/HU224311B1/hu not_active IP Right Cessation
- 1996-07-05 KR KR10-1998-0700023A patent/KR100425401B1/ko not_active Expired - Fee Related
- 1996-07-05 PL PL96323305A patent/PL187704B1/pl not_active IP Right Cessation
- 1996-07-05 EP EP96924889A patent/EP0863752B1/de not_active Expired - Lifetime
- 1996-07-05 DE DE69626301T patent/DE69626301T2/de not_active Expired - Lifetime
- 1996-07-05 JP JP50483397A patent/JP3680950B2/ja not_active Expired - Fee Related
- 1996-07-05 SK SK6-98A patent/SK282874B6/sk not_active IP Right Cessation
- 1996-07-05 ES ES96924889T patent/ES2192608T3/es not_active Expired - Lifetime
- 1996-07-05 ZA ZA9605749A patent/ZA965749B/xx unknown
- 1996-07-05 SI SI9630594T patent/SI0863752T1/xx unknown
- 1996-07-05 AT AT96924889T patent/ATE232723T1/de not_active IP Right Cessation
- 1996-07-05 DK DK96924889T patent/DK0863752T3/da active
- 1996-07-05 CA CA002219678A patent/CA2219678C/en not_active Expired - Fee Related
- 1996-07-05 US US08/981,324 patent/US5935998A/en not_active Expired - Fee Related
- 1996-07-05 WO PCT/EP1996/002970 patent/WO1997002026A1/en not_active Ceased
- 1996-07-05 RU RU98102187/14A patent/RU2193402C2/ru not_active IP Right Cessation
- 1996-07-05 MY MYPI96002783A patent/MY132436A/en unknown
- 1996-07-05 IL IL12285396A patent/IL122853A/en not_active IP Right Cessation
- 1996-07-05 AU AU65195/96A patent/AU715270B2/en not_active Ceased
- 1996-07-05 CZ CZ199817A patent/CZ289440B6/cs not_active IP Right Cessation
- 1996-07-06 TW TW085108161A patent/TW522011B/zh not_active IP Right Cessation
1997
- 1997-12-09 NO NO19975790A patent/NO317496B1/no not_active IP Right Cessation
2004
- 2004-07-02 CY CY0400055A patent/CY2465B1/xx unknown

Also Published As

Publication number	Publication date
DK0863752T3 (da)	2003-04-22
EP0863752B1 (de)	2003-02-19
EP0863752A1 (de)	1998-09-16
HU224311B1 (hu)	2005-07-28
RU2193402C2 (ru)	2002-11-27
ZA965749B (en)	1998-01-05
GB9513750D0 (en)	1995-09-06
WO1997002026A1 (en)	1997-01-23
JPH11508580A (ja)	1999-07-27
CA2219678A1 (en)	1997-01-23
DE69626301D1 (de)	2003-03-27
SK698A3 (en)	1998-05-06
ES2192608T3 (es)	2003-10-16
NO975790L (no)	1997-12-09
NO317496B1 (no)	2004-11-08
AU6519596A (en)	1997-02-05
JP3680950B2 (ja)	2005-08-10
PL323305A1 (en)	1998-03-16
IL122853A0 (en)	1998-08-16
CZ289440B6 (cs)	2002-01-16
IL122853A (en)	2001-04-30
SI0863752T1 (en)	2003-06-30
ATE232723T1 (de)	2003-03-15
US5935998A (en)	1999-08-10
NO975790D0 (no)	1997-12-09
MY132436A (en)	2007-10-31
SK282874B6 (sk)	2003-01-09
CA2219678C (en)	2006-10-10
HK1011527A1 (en)	1999-07-16
KR100425401B1 (ko)	2004-07-16
CZ1798A3 (cs)	1998-03-18
AU715270B2 (en)	2000-01-20
CN1189775A (zh)	1998-08-05
CN1204881C (zh)	2005-06-08
MX9710093A (es)	1998-03-31
HUP9802929A2 (hu)	1999-09-28
DE69626301T2 (de)	2003-10-16
TW522011B (en)	2003-03-01
KR19990028725A (ko)	1999-04-15
HUP9802929A3 (en)	1999-10-28
PL187704B1 (pl)	2004-09-30

Publication	Publication Date	Title
NO960067L (no)	1996-01-05	Nytt farmasöytisk preparat
PL316080A1 (en)	1996-12-23	Pharmaceutic composition for sublingual or intrabuccal administration
SE9401728D0 (sv)	1994-05-18	New compounds II
AU2672995A (en)	1995-12-21	{a}-annelated pyrrole derivatives and pharmaceutical uses thereof
MY113062A (en)	2001-11-30	Amide derivatives and their therapeutic use
SI0863752T1 (en)	2003-06-30	Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases
BR9506956A (pt)	1997-09-16	Composição farmacêutica antitussígena
HU9503692D0 (en)	1996-02-28	Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade
NO973340L (no)	1997-07-18	Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av fedme
AU2796695A (en)	1996-01-15	Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders
CZ176395A3 (en)	1995-12-13	The use of riluzol for preparing medicaments acceptable as antidotes against harmful effects of irradiation